Home Sulfos 1-cyclohexyl-3-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea

1-cyclohexyl-3-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea

CAS No.:
33342-05-1
Catalog Number:
AG0034YT
Molecular Formula:
C27H33N3O6S
Molecular Weight:
527.6324
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$63
- +
5g
98%
In Stock USA
United States
$150
- +
25g
98%
In Stock USA
United States
$450
- +
100g
98%
In Stock USA
United States
$1225
- +
Product Description
Catalog Number:
AG0034YT
Chemical Name:
1-cyclohexyl-3-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea
CAS Number:
33342-05-1
Molecular Formula:
C27H33N3O6S
Molecular Weight:
527.6324
MDL Number:
MFCD00631870
IUPAC Name:
1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
InChI:
InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)
InChI Key:
LLJFMFZYVVLQKT-UHFFFAOYSA-N
SMILES:
COc1ccc2c(c1)C(=O)N(C(=O)C2(C)C)CCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1
EC Number:
251-463-2
UNII:
C7C2QDD75P
Properties
Complexity:
948  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
527.209g/mol
Formal Charge:
0
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
527.636g/mol
Monoisotopic Mass:
527.209g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
130A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.6  
Literature
Title Journal
In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis. Chemico-biological interactions 20151005
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology 20131101
Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage. Journal of toxicology 20120101
Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones. Diabetes & metabolism journal 20110801
Gliquidone. Acta crystallographica. Section E, Structure reports online 20110601
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia. European journal of clinical pharmacology 20110501
Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry. Analytical and bioanalytical chemistry 20110401
Simultaneous determination of gliquidone, pioglitazone hydrochloride, and verapamil in formulation and human serum by RP-HPLC. Journal of chromatographic science 20110201
Effect of glibenclamide on antinociceptive effects of antidepressants of different classes. Clinics (Sao Paulo, Brazil) 20110201
Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes care 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Efficacy of anti-wrinkle products in skin surface appearance: a comparative study using non-invasive methods. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 20101101
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert opinion on drug safety 20100901
Drug therapy in patients with chronic renal failure. Deutsches Arzteblatt international 20100901
Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC. Journal of chromatographic science 20100101
Determination of glycyrrhizin in dog plasma by liquid chromatography-mass spectrometry and its application in pharmacokinetic studies. European journal of mass spectrometry (Chichester, England) 20100101
Twice daily fractionated dose administration of prednisolone compared to standard once daily administration to patients with glomerulonephritis or with kidney transplants. Medizinische Klinik (Munich, Germany : 1983) 20090615
Glucose and pharmacological modulators of ATP-sensitive K+ channels control [Ca2+]c by different mechanisms in isolated mouse alpha-cells. Diabetes 20090201
Sulfonylurea-induced hypoglycaemia: use of octreotide. Acta clinica Belgica 20090101
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ (Clinical research ed.) 20090101
Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes care 20081101
Rapid simultaneous quantification of five active constituents in rat plasma by high-performance liquid chromatography/tandem mass spectrometry after oral administration of Da-Cheng-Qi decoction. Journal of pharmaceutical and biomedical analysis 20080715
Gliquidone therapy of new-onset diabetes mellitus after kidney transplantation. Clinical nephrology 20080701
Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats. Journal of veterinary science 20070901
Simultaneous assay of metformin and glibenclamide in human plasma based on extraction-less sample preparation procedure and LC/(APCI)MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615
Determination of glibenclamide in human plasma by liquid chromatography and atmospheric pressure chemical ionization/MS-MS detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201
Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Molecular pharmacology 20070201
Spectrophotometric method for quantitative determination of gliquidone in bulk drug, pharmaceutical formulations and human serum. Pakistan journal of pharmaceutical sciences 20060701
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Synthesis and antihyperglycemic evaluation of various protoberberine derivatives. Bioorganic & medicinal chemistry letters 20060301
Gliquidone contributes to improvement of type 2 diabetes mellitus management: a review of pharmacokinetic and clinical trial data. Drugs in R&D 20060101
Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes. Indian journal of experimental biology 20050301
Protective effects of glurenorm (gliquidone) treatment on the liver injury of experimental diabetes. Drug and chemical toxicology 20050101
[Effect of liuwei dihuang pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20041201
Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040901
[Gliquidon induced-desensitization of pancreatic beta cells and the partial reversion of responsiveness after the desensitization of exposure to drug in normal and STZ type 2 diabetic rats]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20040501
Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin. Die Pharmazie 20031101
Hydroxyl-substituted sulfonylureas as potent inhibitors of specific [3H]glyburide binding to rat brain synaptosomes. Bioorganic & medicinal chemistry 20030501
[Severe hypoglycemia in diabetics with impaired renal function]. Deutsche medizinische Wochenschrift (1946) 20030207
Effect of pH and complexation on transdermal permeation of gliquidone. Die Pharmazie 20020901
Antiaggregatory activity of hypoglycaemic sulphonylureas. Diabetologia 20020701
Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020615
The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes. Free radical biology & medicine 20011101
Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels. British journal of pharmacology 20011001
Role of K+ -channels in homotaurine-induced analgesia. Fundamental & clinical pharmacology 20010601
Properties